Company Filing History:
Years Active: 2014-2020
Title: The Innovations of Darrell R Abernethy
Introduction
Darrell R Abernethy is a notable inventor based in Annapolis, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating cardiac and pulmonary disorders. With a total of 5 patents, his work has had a profound impact on medical treatments.
Latest Patents
One of his latest patents involves the preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues, which are highly effective at binding β2-adrenergic receptors. This disclosure highlights the discovery of these analogues, which are crucial for treating congestive heart failure and other related conditions. The patent also includes exemplary chemical structures for these analogues, as well as pharmaceutical compositions that incorporate the disclosed compounds. Methods for using these compounds and compositions for treating cardiac disorders such as congestive heart failure and pulmonary disorders like asthma or chronic obstructive pulmonary disease are also provided.
Career Highlights
Darrell R Abernethy is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to focus on innovative research that addresses critical health issues.
Collaborations
Throughout his career, Abernethy has collaborated with esteemed colleagues, including Irving William Wainer and Weizhong Zhu. These partnerships have further enhanced the quality and impact of his research.
Conclusion
Darrell R Abernethy is a distinguished inventor whose work in pharmaceutical innovations has contributed significantly to the treatment of serious health conditions. His patents reflect a commitment to advancing medical science and improving patient outcomes.